William Blair downgraded Cellebrite DI from Outperform to Mkt Perform
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/28/2024 | $13.00 → $13.50 | Buy | Needham |
| 3/13/2024 | Mkt Perform → Outperform | William Blair | |
| 2/16/2024 | $9.00 → $12.00 | Neutral → Buy | BofA Securities |
| 7/19/2023 | $11.00 | Buy | Craig Hallum |
| 8/12/2022 | $6.50 → $6.00 | Buy → Neutral | BofA Securities |
| 8/12/2022 | Outperform → Mkt Perform | William Blair | |
| 2/24/2022 | $10.50 | Overweight | JP Morgan |
| 2/11/2022 | $10.50 | Buy | Deutsche Bank |
6-K - Cellebrite DI Ltd. (0001854587) (Filer)
144 - Cellebrite DI Ltd. (0001854587) (Subject)
144 - Cellebrite DI Ltd. (0001854587) (Subject)
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its third-quarter 2025 financial results after the U.S. market close on Wednesday, November 12, 2025. Later that same day, Cellebrite will host a live conference call and webcast to review the Company's financial results for the third quarter of 2025 and discuss its full-year 2025 outlook. Relevant details include: Date:Wednesday, November 12, 2025Time:5:00 p.m. ETCall-In Number:203-518-9814 / 800-274-8461Conference ID:CLBTQ325Event URL:https://investors.cellebri
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its Autumn 2025 Release, evolving and advancing its Digital Investigation Platform with new integrations and powerful new capabilities that span from collection and review to advanced AI-powered analysis. A key highlight of the Autumn 2025 Release is the addition of Corellium technology available through a reseller agreement, which was established while Cellebrite advances the acquisition process. As a result, the Company now delivers powerful Arm-based mobile virtualization of
ValueAct Capital ("ValueAct"), a global investment firm with a position of approximately 7.8% of the shares outstanding in SUNCORPORATION (TSE: 6736), today filed a Large Shareholding Report with Kanto Zaimukyoku (Kanto Local Finance Bureau) in Japan. Commenting on the investment, ValueAct Capital Co-CEO Rob Hale said, "ValueAct is pleased to become a large shareholder of Sun Corp. We have great respect for Sun's businesses and especially their historical sponsorship of Cellebrite (NASDAQ:CLBT), the world's leading digital investigations platform. We believe that Sun is on a path to maximize the value of their Cellebrite investment, and that all stakeholders of both companies stand to ben
Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously
William Blair upgraded Cellebrite DI from Mkt Perform to Outperform
BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously
TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its agreement to acquire Corellium, a leader in Arm-based virtualization software. This combination will set a new standard for digital investigations and the security of smart devices including iOS, Android, automotive systems and any Arm-based IoT device. Customers across public safety, defense, intelligence and private sectors will benefit from: Accelerated identification of mobile vulnerabilities and exploitsIndustry-first ability to visualize and interact with virtual dev
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its third-quarter 2025 financial results after the U.S. market close on Wednesday, November 12, 2025. Later that same day, Cellebrite will host a live conference call and webcast to review the Company's financial results for the third quarter of 2025 and discuss its full-year 2025 outlook. Relevant details include: Date:Wednesday, November 12, 2025Time:5:00 p.m. ETCall-In Number:203-518-9814 / 800-274-8461Conference ID:CLBTQ325Event URL:https://investors.cellebri
Thomas E. Hogan Named CEO ARR grew 21% to $418.9 million; Revenue grew 18% to $113.3 million Net income of $19.5 million supports non-GAAP net income of $30.8 million and adjusted EBITDA of $27.9 million, 24.6% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and six months ending June 30, 2025 and the appointment of Thomas E. Hogan as the Company's CEO. "Cellebrite delivered a strong balance of top-line growth, profitability and cash flow," stated Thomas E. H
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that David Barter, a proven finance executive with extensive public company CFO experience in technology and software, has been appointed CFO, effective immediately. He succeeds Dana Gerner, who has served as Cellebrite's CFO since 2014. Gerner will remain in an active advisory role to support the transition until the Company reports its second-quarter 2025 financial results. As CFO, Barter is responsible for the Company's financial operations, including financial planning, acco
SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)